Butantan Institute's dengue vaccine protects
<p>Data from the Phase 3 clinical trial was published today (Thursday) in&nbsp;<em>The New England Journal of Medicine</em>. The vaccine is safe for both participants who have had dengue and those who have never been exposed to the virus before.</p>
Lacerda Nogueira Neuza Frazatti Gallina Esper Kall Sanofi Pasteur Butantan Institute Method Of Research
Source: eurekalert.org